FDA Warns Marketers of Unapproved 'Chelation' Drugs

Oct 14, 2010, 15:52 ET from U.S. Food and Drug Administration

SILVER SPRING, Md., Oct. 14 /PRNewswire-USNewswire/ -- Federal regulators are warning eight companies to stop selling nonprescription products that claim to treat a range of disorders from autism to Alzheimer's disease.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)  

The companies say their products work through a process called chelation, which removes toxic metals from the body. The Food and Drug Administration says the companies are making unsubstantiated claims, which is a violation of federal law. FDA experts say even the approved, prescription chelation drugs have risks and should only be used with medical supervision.

To find out what companies received FDA warning letters, go to http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm 229358.htm.

Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.

View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml.

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

Contact: Jason Brodsky of FDA, +1-301-796-8234, Jason.Brodsky@fda.hhs.gov

SOURCE U.S. Food and Drug Administration